« Previous
Next »
Epilepsy Research
Volume 24, Issue 1
, Pages 19-28
, May 1996
Lamotrigine vs. phenytoin for treatment of status epilepticus: comparison in an experimental model
References
- . Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia): I. Antiepileptic actions. Epilepsia. 1992;33:743–752
-
.
Treatment of convulsive status epilepticus.
J. Am. Med. Assoc. 1993;270:854–859
- . A liquid chromatographic assay using a high-speed column for the determination of lamotrigine, a new antiepileptic drug, in human plasma. Ther. Drug Monit. 1992;14:509–512
- . NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures. Epilepsy Res. 1991;5:103–111
- . Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition. J. Neurophysiol. 1989;61:417–426
- . Pharmacological studies on lamotrigine, a novel potential antiepileptic drug. II. Neurochemical studies on the mechanism of action. Epilepsia. 1986;27:490–497
-
.
A simplified method of evaluating dose-effect experiments.
J. Pharmacol. Exp. Ther. 1949;96:99–113
- . Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci. Lett. 1991;128:150–154
- . Antiepileptic drug mechanisms of action. Epilepsia. 1995;36(Suppl. 2):S2–S12
- . Gabapentin. Epilepsia. 1995;36(Suppl. 2):S73–S86
- . Lamotrigine. Epilepsia. 1995;36(Suppl. 2):S87–S94
- . Reduction of paired pulse inhibition in the CA1 region of the hippocampus in status epilepticus induced by pilocarpine in naive and in amygdala-kindled rats. Exp. Neurol. 1989;104:264–271
- . Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I: anticonvulsant profile in mice and rats. Epilepsia. 1986;27:483–489
- . The delayed effect of sodium valproate on the photoconvulsive response in man. Epilepsia. 1979;20:61–68
- . Emerging perspectives on the mechanism of action of gabapentin. Neurology. 1994;44(Suppl. 5):S10–S16
-
.
Duration of generalized convulsive status epilepticus (GCSE): relationship to clinical symptomatology and response to treatment.
Epilepsia. 1992;33(Suppl. 3):67
- . Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine. Epilepsy Res. 1994;19:237–244
- . Experimental secondarily generalized convulsive status epilepticus induced by D,L-homocysteine thiolactone. Epilepsy Res. 1988;2:79–86
- . Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Exp. Neurol. 1988;101:267–275
- . Phenobarbital treatment of status epilepticus in a rodent model. Epilepsy Res. 1989;4:216–221
- . Efficacy of ACC-9653 (a phenytoin prodrug) in experimental status epilepticus in the rat. Epilepsy Res. 1990;5:165–168
- . Lorazepam treatment of experimental status epilepticus in the rat: relevance to clinical practice. Neurology. 1990;40:990–994
- . Vaproic acid treatment of experimental status epilepticus. Epilepsy Res. 1992;12:199–205
-
.
Efficacy of a new NMDA receptor antagonist in treatment of experimental status epilepticus.
Epilepsia. 1993;34(Suppl. 6):52
-
.
Statistical Principles in Experimental Design.
In: New York, NY: McGraw-Hill; 1962;p. 907
PII: 0920-1211(96)00007-1
« Previous
Next »
Epilepsy Research
Volume 24, Issue 1
, Pages 19-28
, May 1996
